Abstract
The combination of pyrimethamine and clindamycin, both administered orally, was evaluated for initial and maintenance therapy of toxoplasmosis in eight AIDS patients who were either allergic to sulfonamides or unresponsive to standard therapy. Symptomatic and neuroradiographic improvement occurred in the majority of patients. The regimen was well tolerated and associated with minimal toxicity, and appeared to be an effective alternative to standard therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Snider WD, Simpson DM, Nielson S, Gold JWM, Metroka CE, Posner JB Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Annals of Neurology 1983, 14: 403–418.
Luft BJ, Brooks RG, Conley FK, McCabe RE, Remington JS Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. Journal of the American Medical Association 1984, 252: 913–917.
Gordin FM, Simon GL, Wofsy CB, Mills J Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Annals of Internal Medicine 1984, 100: 495–499.
Hofflin JM, Remington JS Clindamycin in a murine model of toxoplasmic encephalitis. Antimicrobial Agents and Chemotherapy 1987, 31: 492–496.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rolston, K.V.I. Treatment of acute toxoplasmosis with oral clindamycin. Eur. J. Clin. Microbiol. Infect. Dis. 10, 181–183 (1991). https://doi.org/10.1007/BF01964456
Issue Date:
DOI: https://doi.org/10.1007/BF01964456